Welcome to the Jungle: Probiotics in the Preterm Infant

Program Date: 27 February 2020
Publication Date: 10 December 2019
Continuing Education Units: Nurse Contact: 1.0; Dietitian CPEU: 1.0

Course Description:

In this course, you’ll discuss the alteration of the gut microbiome in preterm infants; review recent evidence-based literature on probiotic use in the NICU; and discuss the risks vs. benefits with the use of probiotics in preterm infants.

Course Objectives:

•Discuss the alteration of the gut microbiome in preterm infants leading to dysbiosis and associated morbidities.
•Review recent evidence-based literature on probiotic use in the NICU.
•Discuss the risks vs. benefits with the use of probiotics in preterm infants.
  • CDR Level: 1
  • Suggested Learning Codes: 4040, 5000, 5060, 9020
  • Performance Indicators: 4.1.2, 8.1.2, 8.1.4, 8.3.6
  • Run Time: 42

Course Instructor Bio(s)

Steven J. McElroy, MD

Assistant Professor, Pediatrics
University of Iowa
Iowa City, IA, USA
Dr. Steven McElroy is an Associate Professor of Pediatrics – Neonatology, and an Associate Professor of Microbiology and Immunology at the University of Iowa. His current research and work focus is on the mechanisms of gastrointestinal epithelial cell injury and repair during development, especially as it relates to neonatal necrotizing enterocolitis (NEC). The long-term goal is to better understand how different gastrointestinal developmental stages differ in their response to inflammation, and specifically the mechanism by which immaturity of the small intestine predisposes development of NEC. His laboratory developed a novel model of NEC [in mice] that uses Paneth cell ablation to induce intestinal pathology that is consistent with human NEC.
enroll.svg
ENROLL NOW

You Must LOG IN to Enroll

certificate-icon

attended a live program?

question-marks

FREQUENTLY ASKED QUESTIONS

medical-education

continuing medical education courses

Earn CME credits at no cost to you.